# Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults

> **NCT01386164** · PHASE4 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 92 (actual)

## Conditions studied

- HIV
- Human Papillomavirus

## Interventions

- **BIOLOGICAL:** Gardasil
- **BIOLOGICAL:** Cervarix

## Key facts

- **NCT ID:** NCT01386164
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-12
- **Final completion:** 2013-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2013-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386164, "Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01386164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*